Our results suggest that human ESC (hESC)- or induced pluripotent stem cell (iPSC)-derived TEPs, especially APP−/− hESC or iPSC-TEPs, may serve as a novel tool to modify AD pathology. This evidence concerns the gene APP and Alzheimer disease.